Abstract
In a variety of stimulated cells, platelet-activating factor (PAF) and numerous arachidonate derivatives are coproducts that form as a consequence of receptor-mediated phospholipid mobilization. These lipid co-products produce a plethora of biological effects in a wide variety of cell systems. Furthermore, they often have a fascinating, although less widely appreciated, interaction. 5-HETE, at submicromolar concentrations, exerts relatively few direct bioactions. It does, however, potently (16–160 nM) raise cytosolic free calcium [Ca2+]i and augment PAF-induced responses in human polymorphonuclear neutrophils (PMN) by as much as 100- to 1000-fold. 5-HETE acts on PMN by a structurally specific, stereospecific and pertussis toxin-inhibitable mechanism. In addition, PMN exposed to 5-HETE exhibit homologous but not heterologous desensitization. These findings suggest that 5-HETE, like PAF, may bind to its own specific plasmalemmal receptors to exert its unique set of bioactions. However, further investigation is required to demonstrate any putative 5-HETE receptors. Other potential mechanisms of 5-HETE-induced bioactions together with the possible effects of 5-HETE on PAF transduction mechanisms are also discussed.
Similar content being viewed by others
Abbreviations
- [Ca2+]i :
-
cytosolic free calcium ions
- DAG:
-
diacylglycerol
- G-proteins:
-
guanine nucleotide-binding proteins
- HETE:
-
hydroxyicosatetraenoate
- HPETE:
-
hydroperoxyicosatetraenoate
- IP3 :
-
inositol 1,4,5-triphosphate
- LT:
-
leukotriene
- PAF:
-
platelet-activating factor
- PG:
-
prostaglandin
- PIP2 :
-
phosphatidylinositol 4,5-bisphosphate
- PKC:
-
protein kinase C
- PL:
-
phospholipase
- PMN:
-
polymorphonuclear neutrophils
- R:
-
receptor
- S:
-
stimulus
- TX:
-
thromboxane
References
Irvine, R.F. (1982)Biochem. J. 204, 3–16.
O'Flaherty, J.T. (1987)Biochem. Pharmacol. 36, 407–412.
Berridge, M.J., and Irvine, R.F. (1984)Nature 312, 315–321.
Nishizuka, Y. (1986)Science 233, 305–312.
Abdel-Latif, A.A. (1986)Pharmacol. Rev. 38, 227–272.
Berridge, M.J. (1987)Ann. Rev. Biochem. 56, 159–193.
Gilman, A.G. (1987)Ann. Rev. Biochem. 56, 615–649.
Freissmuth, M., Casey, P.J., and Gilman, A.G. (1989)FASEB J. 3, 2125–2131.
Downes, C.P. (1989)Biochem. Soc. Trans. 17, 259–268.
Wykle, R.L., Olson, S.C., and O'Flaherty, J.T. (1986)Adv. Inflam. Res. 11, 71–81.
Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.
Snyder, F. (1989)Proc. Soc. Exp. Biol. Med. 190, 125–135.
Samuelsson, B. (1983)Science 220, 568–575.
O'Flaherty, J.T. (1982)Lab. Invest. 47, 314–329.
Piper, P.J. (1984)Physiol. Rev. 64, 744–761.
Vanderhoek, J.Y. (1985) inBiochemistry of Arachidonic Acid Metabolism (Lands, W.E.M., ed.) Ch. 13, pp. 213–226, Martinus Nijhoff Publishing, Boston.
Spector, A.A., Gordon, J.A., and Moore, S.A. (1988)Prog. Lipid Res. 27, 271–323.
Samuelsson, B., Dahlen, S-E., Lindgren, J., Rouzer, C.A., and Serhan, C.N. (1987)Science 237, 1171–1176.
Barnes, P.J., Chung, K.F., and Page, C.P. (1988)Pharmacol. Rev. 40, 49–84.
Belch, J.J.F. (1989)Prostaglandins Leukotrienes and Essential Fatty Acids 36, 219–234.
Nishihira, J., and Ishibashi, T. (1986)Lipids 21, 780–785.
Okayasu, T., Hoshii, K., Seyama, K., Ishibashi, T., and Iami, Y. (1986)Biochim. Biophys. Acta 876, 58–64.
Wykle, R.L., Kraemer, W.F., and Schremmer, J.M. (1980)Biochim. Biophys. Acta 619, 58–67.
Kawasaki, T., and Snyder, F. (1987)Biochim. Biophys. Acta 920, 85–93.
Valone, F.H., Coles, E., Reinhold, V.R., and Goetzl, E.J. (1982)J. Immunol. 129, 1637–1641.
Hwang, S-B., Lee, C-S.C., Cheah, M.J., and Shen, T.Y. (1983)Biochemistry 22, 4756–4763.
O'Flaherty, J.T., Surles, J.R., Redman, J., Jacobson, D., Piantadosi, C., and Wykle, R.L. (1986)J. Clin. Invest. 78, 381–388.
Lapetina, E.G. (1982)J. Biol. Chem. 257, 7314–7317.
Shulka, S.D., and Hanahan, D.J. (1982)Biochem. Biophys. Res. Commun. 106, 697–703.
Mauco, G., Chap, H., and Douste-Blazy, L. (1983)FEBS Letters 153, 361–365.
MacIntyre, D.E., and Pollock, W.K. (1983)Biochem. J. 212, 433–437.
Rossi, A.G., McMillan, R.M., and MacIntyre, D.E. (1988)Agents and Actions 24, 272–282.
Chilton, F.H., O'Flaherty, J.T., Walsh, C.E., Thomas, M.J., Wykle, R.L., DeChatelet, L.R., and Waite, B.M. (1982)J. Biol. Chem. 257, 5402–5407.
Lin, A.H., Morton, D.R., and Gorman, R.R. (1982)J. Clin. Invest. 70, 1058–1065.
Lad, P.M., Olson, C.V., and Grewal, I.S. (1985)Biochem. Biophys. Res. Commun. 129, 632–638.
Naccache, P.H., Molski, M.M., Volpi, M., Becker, E.L., and Sha'afi, R.I. (1985)Biochem. Biophys. Res. Commun. 130, 677–684.
Naccache, P.H., Molski, M.M., Volpi, M., Shefcyk, J., Molski, T.F.P., Loew, L., Becker, E.L., and Sha'afi, R.I. (1986)J. Leukocyte Biol. 40, 533–548.
Houslay, M.D., Bojanic, D., and Wilson, A. (1986)Biochem. J. 234, 737–740.
Verghese, M.W., Charles, L., Jakoi, L., Dillon, S.B., and Snyderman, R. (1987)J. Immunol. 138, 4374–4380.
Valone, F.H. (1987)Thromb. Res. 45, 427–435.
Doebber, T.W., and Wu, M.S. (1987)Proc. Natl. Acad. Sci. USA 84, 7557–7561.
Tessner, T.G., O'Flaherty, J.T., and Wykle, R.L. (1989)J. Biol. Chem. 264, 4794–4799.
Johnson, M., Carey, F., and MacMillan, R.M. (1983)Essays Biochem. 19, 40–141.
Yamamoto, S. (1989)Prostaglandins, Leukotrienes and Essential Fatty Acids 35, 219–229.
Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E., and Smith, M.J.H. (1980)Nature 286, 264–265.
Bray, M.A. (1983)Br. Med. Bull. 39, 249–254.
Sirois, P., Borgeat, P., Jeanson, A., Roy, S., and Girard, G. (1980)Prostaglandins Med. 5, 429–444.
Sirois, P., Borgeat, P., and Jeanson, A. (1981)J. Pharm. Pharmacol. 33, 466–468.
Sirois, P., Roy, S., and Borgeat, P. (1981)Prostaglandins Med. 6, 153–159.
Goldman, D.W., and Goetzl, E.J. (1982)J. Immunol. 129, 1600–1604.
Kreisle, R.A., and Parker, C.W. (1983)J. Exp. Med. 157, 628–641.
Goldman, D.W., and Goetzl, E.J. (1984)J. Exp. Med. 159, 1027–1041.
O'Flaherty, J., Kosfeld, S., and Nishihira, J. (1986)J. Cell. Physiol. 126, 359–370.
Stenson, W.F., and Parker, C.W. (1979)J. Clin. Invest. 64, 1457–1465.
Bonser, R.W., Siegel, M.I., Chung, S.M., McConnell, R.T., and Cuatrecasas, P. (1981)Biochemistry 20, 5297–5301.
Bonser, R.W., Siegel, M.I., McConnell, R.T., and Cuatrecasas, P. (1981)Biochem. Biophys. Res. Commun. 102, 1269–1275.
O'Flaherty, J.T., Wykle, R.L., Redman, J., Samuel, M., and Thomas, M. (1986)J. Immunol. 137, 3277–3283.
Powell, W.S. (1984)J. Biol. Chem. 259, 3082–3089.
Hansson, G., Lindgren, J.A., Dahlen, S-E., Hedqvist, P., and Samuelsson, B. (1981)FEBS Letters 130, 107–112.
Camp, R.D.R., Woollard, P.M., Mallet, A.I., Fincham, N.J., Ford-Hutchinson, A.W., and Bray, M.A. (1982)Prostaglandins 23, 631–641.
Jubiz, W., Radmark, O., Malmsten, C., Hansson, G., Lindgren, J.A., Palmblad, J., Uden, A.-M., and Samuelsson, B. (1982)J. Biol. Chem. 257, 6196–6110.
Naccache, P.H., Molski, T.F.P., Becker, E.L., Borgeat, P., Picard, S., Vallerand, P., and Sha'afi, R.I. (1982)J. Biol. Chem. 257, 8608–8611.
Granstrom, E., and Kumlin, M. (1987) inProstaglandins and Related Substances (Benedetto, C., McDonald-Gibson, R.G., Nigam, S., and Slater, T.F., eds.) Ch. 2, pp. 5–27, IRL Press, Oxford, England.
Palmer, R.M.J., Stepney, R.J., Higgs, G.A., and Eakins, K.E. (1980)Prostaglandins 20, 411–418.
Goetzl, E.J., Brash, A.R., Tauber, A.I., Oates, J.A., and Hubbard, W.C. (1980)Immunol. 39, 491–501.
Goetzl, E.J., and Pickett, W.C. (1980)J. Immunol. 125, 1789–1791.
Goetzl, E.J., Weller, P.F., and Sun, F.F. (1980)J. Immunol. 124, 926–933.
Konig, W., KRoegel, C., Kunau, H.W., and Borgeat, P. (1981)Int. Archs. Allergy Appl. Immun. 66, 168–171.
Stenson, W.F., and Parker, C.W. (1980)J. Immunol. 124, 2100–2104.
Bokoch, G.M., and Reed, P.W. (1981)J. Biol. Chem. 256, 5317–5320.
O'Flaherty, J.T., Thomas, M.J., Lees, C.J., and McCall, C.E. (1981)Am. J. Pathol. 104, 55–62.
Bass, D.A., Thomas, M.J., Goetzl, E.J., DeChatelet, L.R., and McCall, C.E. (1981)Biochem. Biophys. Res. Commun. 100, 1–7.
Thomas, M.J., O'Flaherty, J.T., Cousart, S., and McCall, C.E. (1982)Prostaglandins 23, 265–272.
Copas, J.L., Borgeat, P., and Gardiner, P.J. (1982)Prostaglandins Leukotrienes Med. 8, 105–114.
Yamamoto, S., Ishii, M., Nakadate, T., Nakaki, T., and Kato, R. (1983)J. Biol. Chem. 258, 12149–12152.
Naor, Z., Vanderhoek, J.Y., Lindner, H.R., and Catt, K.J. (1983) inAdvances in Prostaglandin, Thromboxane and Leukotriene Research (Samuelsson, B., Paoletti, R., and Ramwell, P., eds.) Vol. 12, pp. 259–263, Raven Press, New York.
Shelhamer, J.H., Marom, Z., Sun, F., Bach, M.K., and Kaliner, M. (1982)Chest 81, 36S-37S.
Stenson, W.F., and Lobos, E. (1981)Gastroenterology 80, 1293.
Musch, M.W., Miller, R.J., Field, M., and Siegel, M.I. (1982)Science 217, 1255–1256.
Naccache, P.H., Sha'afi, R.I., Borgeat, P., and Goetzl, E.J. (1981)J. Clin. Invest. 67, 1584–1587.
O'Flaherty, J.T., and Nishihira, J. (1987)Biochem. Biophys. Res. Commun. 148, 575–581.
O'Flaherty, J.T., Jacobson, D., and Redman, J. (1988)J. Immunol. 140, 4323–4328.
Rossi, A.G., Thomas, M.J., and O'Flaherty, J.T. (1988)FEBS Letters 240, 163–166.
O'Flaherty, J.T., Thomas, M.J., Hammett, M.J., Carroll, C., McCall, C.E., and Wykle, R.L., (1983)Biochem. Biophys. Res. Commun. 111, 1–7.
O'Flaherty, J.T., Schmitt, J.D., and Wykle, R.L. (1985)Biochem. Biophys. Res. Commun. 127, 916–923.
O'Flaherty, J.T., Thomas, M.J., McCall, C.E., and Wykle, R.L. (1983)Res. Commun. Chem. Pathol. Pharmacol. 40, 475–487.
O'Flaherty, J.T., Wykle, R.L., Thomas, M.J., and McCall, C.E. (1984)Res. Commun. Chem. Pathol. Pharmacol. 43, 3–23.
O'Flaherty, J.T. (1985)J. Cell. Physiol. 122, 229–239.
O'Flaherty, J.T., and Nishihira, J. (1987)J. Immunol. 138, 1889–1895.
O'Flaherty, J.T., and Nishihira, J. (1987)Advances in the Biosciences 66, 251–253.
O'Flaherty, J.T. (1988) inProstaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids (Curtis-Prior, P.B., ed.) Ch. 55, pp. 663–670, Churchill Livingstone, Edinburgh, U.K.
O'Flaherty, J.T., and Nishihira, J. (1987) inNew Horizons in Platelet Activating Factor Research (Winslow, C.M., and Lee, M.L., eds.) Ch. 13, pp. 131–136, John Wiley & Sons, Ltd., London.
Saito, H., Hirai, A., Tamura, Y., and Yoshida, S. (1985)Prostaglandins Leukotriene Med. 18, 271–286.
Billah, M.M., Bryant, R.W., and Siegel, M.I. (1985)J. Biol. Chem. 260, 6899–6906.
Peters, S.P., Siegel, M.I., Kagey-Sobotka, A., and Lichtenstein, L.M. (1981)Nature 292, 455–457.
Peters, S.P., Kagey-Sobotka, A., MacGlashan, D.W., Jr., Siegel, M.I., and Lichtenstein, L.M. (1982)J. Immunol. 129, 797–803.
Stenson, W.F., Parker, C.W., and Sullivan, T.J. (1980)Biochem. Biophys. Res. Commun. 96, 1045–1052.
Siegel, M.I., McConnell, R.T., Bonser, R.W., and Cuatrecasas, P. (1982)Biochem. Biophys. Res. Commun. 104, 874–881.
Malo, P.E. (1989)Prostaglandins 37, 539–551.
Krause, K-H., and Lew, D.P. (1988)Sem. Hematol. 25, 112–122.
Mexmain, S., Gualde, N., Aldigier, J.C., Motta, C., Chable-Rabinovitch, H. (1984)Prostaglandins Leukotrienes Med. 13, 93–97.
Rabier, M., Crastes de Paulet, A., and Damon, M. (1988)Biochem. Biophys. Res. Commun. 152, 1179–1184.
Badwey, J.A., Robinson, J.M., Horn, W., Soberman, R.J., Karnovsky, M.J., and Karnovsky, M.L. (1988)J. Biol. Chem. 263, 2779–2786.
Author information
Authors and Affiliations
About this article
Cite this article
Rossi, A.G., O'Flaherty, J.T. Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor. Lipids 26, 1184–1188 (1991). https://doi.org/10.1007/BF02536528
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536528